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ABSTRACT OF DISSERTATION 
 
 
 
 
A CONTROLLED COMPARISON OF  
EMOTIONAL REACTIVITY AND PHYSIOLOGICAL  
 RESPONSE IN CHRONIC OROFACIAL PAIN PATIENTS 
 
This study examined the emotional and physiological differences between 
masticatory muscle pain patients and age, height, and weight matched pain-free controls.  
Physiological activation and emotional reactivity were assessed in the 22 muscle pain 
patients and 23 pain-free controls during a baseline rest period, while discussing a 
personally relevant stressor, and during a post-stressor recovery period.  Physiological 
activity was assessed through the use of the frequency domain heart rate variability 
indices.  Activity in the high frequency heart rate variability range is an index of 
parasympathetic activity while activity in the low frequency heart rate variability range is 
an index of both sympathetic and parasympathetic activity (Akselrod, 1981).  The muscle 
pain patients showed significantly more physiological activation during both the baseline 
rest and the post-stressor recovery periods.  These physiological differences were 
quantified by higher low frequency heart rate variability and lower high frequency heart 
rate variability during these study periods.   This pattern of higher activation was also 
present in the report of emotional reactivity in the muscle pain patients.  The emotional 
and physiological differences between the groups across study periods were more 
pronounced in muscle pain patients who reported a traumatic life experience. These 
results provide evidence of physiological activation and emotional responding in 
masticatory muscle pain patients that differentiates them from matched pain-free 
controls.  The use of HRV indices to measure physiological functioning quantifies the 
degree of sympathetic and parasympathetic activation.  Study results suggest the use of 
these HRV indices will improve understanding of the role that excitatory and inhibitory 
mechanisms play in the onset and maintenance of chronic masticatory muscle pain 
conditions. 
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Chapter One 
Introduction 
Background  
Orofacial pain occurs within the umbrella of Temporomandibular Disorders 
(TMD), and is one of the most common regional pain syndromes (Macfarlane et al., 
2002).  These conditions are primarily present in young and middle-aged adults and are 
less common among children or the elderly.  There is also a large gender difference, with 
women twice as likely to report a TMD problem (LeResche, 1997).  Orofacial pain may 
arise after a temporomandibular joint suffers injury and mechanical function is impaired.  
Poor functional habits such as grinding the teeth or habitual tensing of the jaw 
musculature may also initiate a TMD or exacerbate an already existing TMD.  A recent 
epidemiological study found 5.3% of the US population to be experiencing some form of 
TMD pain (Lipton, Ship, & Larach-Robinson, 1993).  Other prevalence studies have 
placed the incidence of TMD even higher, at about 12% (Von Korff, Dworkin, LeResche, 
& Kruger, 1988).  As with most chronic problems, these conditions are associated with 
high health care costs and lost productivity (White, Williams, & Leben, 2001).  
Contributing to these high costs and loss of productivity is likely the high incidence of 
comorbid physiological conditions present in orofacial pain patients (e.g., interstitial 
cystitis, fibromyalgia, GERD) and suggests broad physiological dysfunction (Aaron, 
Burke, & Buchwald, 2000).  Clearly, an orofacial pain condition can be a complex 
problem with potentially wide-ranging physiological effects.  
Compared to pain-free controls, chronic orofacial pain patients have reported 
lower pain tolerance and thresholds (Maixner, Fillingim, Booker, & Sigurdsson, 1995), 
more emotional and cardiovascular reactivity (Curran, Carlson, & Okeson, 1996), more 
psychological distress, more fatigue, and more sleep dysfunction (Carlson et al., 1998).  
Several studies have also demonstrated the comorbidity and increased incidence of 
anxiety (Kight, Gatchel, Ellis, & Holt, 1999; McNeil et al., 2001) and depression (Banks 
& Kerns, 1996) in orofacial pain patients.  These characteristics may reflect a more 
fragile and reactive behavioral response system.  In fact, orofacial pain patients have 
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demonstrated heightened emotional reactivity to stressors.  For example, Curran and 
colleagues found that patients with masticatory muscle pain responded to a standard math 
stressor (serial subtraction) with more anger when compared to controls (Curran et al., 
1996).  In a similar study, however, Carlson and colleagues found significant emotional 
and physiological responses in both an orofacial pain sample and matched controls to a 
standard math stressor (serial subtraction) (Carlson et al., 1998).  The lack of significant 
differences in emotional responding between patients and controls after exposure to a 
standard stressor may reflect study design or measurement issues.  It has been suggested 
that the use of a personally-relevant stressor is critical in differentiating TMD patients 
from controls on physiological domains (Flor, Birbaumer, Schugen, & Lutzenberger, 
1992; Flor, Birbaumer, Schulte, & Roos, 1991; Ohrbach, Blascovich, Gale, McCall, & 
Dworkin, 1998).   
Another feature of these patients is comorbidity to traumatic events.  A recent 
study found 49.8% of over twelve hundred orofacial pain patients reported traumatic life 
events (de Leeuw, Bertoli, Schmidt, & Carlson, 2005b).  The incidence of orofacial pain 
patients reporting clinically significant symptomatology of PTSD is also high, ranging 
from 15% to 23% (de Leeuw, Bertoli, Schmidt, & Carlson, 2005a; Sherman, 1998; 
Sherman, Carlson, Wilson, Okeson, & McCubbin, 2005).  A diagnosis of PTSD is 
associated with persistent hyperarousal as well as increased physiological reactivity when 
exposed to a reminder of the traumatic event (DSM-IV).  These factors likely contribute 
to a reduction in the range of behavioral regulation and an increase in emotional 
reactivity. 
The systemic and chronic level of activation present in orofacial pain patients, 
that are even more pronounced in patients reporting a traumatic stressor, does not seem to 
easily abate or subside over time.  The characteristics commonly found in chronic 
orofacial pain patients of increased emotional reactivity, increased incidence of 
psychopathology, and increased physiological reactivity imply a compromised autonomic 
regulation system and suggests the need for a quantitative measure of autonomic system 
regulation and response.  A physiological measure representative of autonomic balance 
would provide a better understanding of the associations among emotional and 
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physiological response to environmental challenge by providing an index of autonomic 
homeostasis and flexibility.  Heart rate variability is a physiological index that has 
demonstrated usefulness in providing a quantitative measure of sympathetic and 
parasympathetic activity, and is a good candidate to index autonomic balance.   
 
Heart Rate Variability 
Heart rate variability (HRV) is an index of fluctuations in the time interval 
between normal heartbeats.  Fluctuations in inter-beat interval are expressed as beat-to-
beat alterations in heart rate and are a representation of the heart’s ability to respond to 
normal regulatory impulses that affect heart rhythm (Akselrod, 1995).  This index is 
commonly presented as a function of power at different frequency ranges of heart 
functioning.  The lower frequency range (LF) includes both sympathetic and 
parasympathetic influences (Chiu & Kao, 2001).  Basic studies using atropine and similar 
drugs that block or dampen vagal stimulation to the heart have resulted in strongly 
reduced LF power (Akselrod et al., 1985; Akselrod, Gordon, & Ubel, 1981).  The higher 
frequency range (HF) reflects vagal activity and is thus parasympathetically modulated 
(Akselrod et al., 1981).  Increased HF power has been associated with higher 
parasympathetic activity in studies of paced breathing (Ring et al., 1999) and treatment 
for depression (Carney, Freedland, & Stein, 2000).  Total vagal blockade essentially 
eliminates the power in the HF range, and reduces power in the LF range.  With gradual 
blockade of vagal input, the ratio of LF to HF power increases, demonstrating a shift in 
the sympathovagal equilibrium towards sympathetic dominance (Malliani, Pagani, 
Lombardi, & Cerutti, 1991).    
Basic research into demographic and physiological correlates of HRV has shown 
an association with age (Carter, Banister, & Plaber, 2003; Fagard, Pardaens, & Staessen, 
1999), regular exercise and aerobic fitness (Carter et al., 2003), and genetic factors 
(Singh, Larson, O'Donnell, & Levy, 2001).  Functionally, respiration pattern is a major 
component in the study of HRV.  Respiratory Sinus Arrhythmia (RSA) refers to the 
cyclical fluctuations in heart rate that coincide with respiratory cycle.  Heart rate 
increases during inspiration and decreases during exhalation.  In HRV frequency indices, 
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RSA is reflected in the HF range and has been used as a non-invasive measure of 
parasympathetic function (Task Force, 1996).  
 
Heart Rate Variability and Trauma 
The ability of HRV to provide a quantitative index of autonomic functioning is 
most apparent in studies of trauma survivors suffering from posttraumatic stress disorder 
(PTSD).  A diagnosis of PTSD may result in reduced HRV, reduced emotional inhibition, 
and a lack of behavioral flexibility in stressful situations.  To test these hypotheses, 
Cohen and colleagues conducted two studies (1998, 2000) comparing PTSD patients with 
age and sex matched controls on HRV indices while resting, when discussing a 
personally relevant stressor, and post-stressor.  The pattern of autonomic response in the 
PTSD participants showed no significant change across study periods, while the control 
group showed a decrease in HF and an increase in LF during the stressor period 
compared to the baseline and post periods (Cohen et al., 2000; Cohen et al., 1998).  The 
response to recalling a distressing event by the control group appears to represent a 
normal and well-balanced autonomic reaction.  In contrast, the response of the PTSD 
patients demonstrates a lack of heart rate variability in either a restful or distressing state.  
This rigidity of autonomic activity may reflect the constant state of hyperactivation 
characterized by increased sympathetic activity and decreased parasympathetic activity in 
PTSD sufferers.  These physiological characteristics of the PTSD patients in these studies 
suggest chronic dis-inhibition of sympathetic activity.  
Engaging in inhibitory control of sympathetic activity after a stressor likely 
represents a healthy, balanced psychophysiological response system, while dis-inhibition 
of sympathetic activity suggests psychophysiological inflexibility.   Thayer has 
developed a model of neurovisceral integration (Thayer & Lane, 2000), which seeks to 
demonstrate how anxiety related arousal represents a disinhibition of positive feedback 
circuits normally under tonic inhibitory control.  This model strives to account for the 
interactions of cognitive, affective, behavioral, and physiological states and dispositions 
across the spectrum of normal and pathological functioning.  A reduction in overall 
system flexibility is thought to result from a disinhibition of sympathetic nervous system 
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activity.  When vagal input to the heart is decreased, the individual is less able to track 
rapid changes in environmental demands due to the slow response of sympathetic input.  
Instead of the negative feedback loop associated with increased parasympathetic 
functioning and subsequent inhibition of sympathetic activation after arousal, a positive 
feedback loop becomes dominant in situations where there is sustained attention or 
vigilance to environmental stimuli (Porges, 1992; Thayer & Lane, 2000).  Thayer 
proposes that autonomically mediated HRV provides an index of neurovisceral 
integration and system flexibility by providing quantitative values of sympathetic and 
parasympathetic activity present at the sino-atrial node of the heart.   
The use of heart rate variability to investigate autonomic activity in orofacial pain 
patients might broaden the understanding of the dynamic relationships among emotional 
reactivity, negative life experiences, and the development of a chronic pain condition.  
Further, the information provided by a focused and controlled analyses of HRV with 
orofacial pain patients may provide a distinct quantitative index of autonomic regulation 
and demonstrate a consistent pattern of behavioral disinhibition in these patients.   
 
Study Aims and Hypotheses 
The present study has two general aims.  First, this study investigated differences 
in heart rate variability indices between chronic orofacial pain patients and pain-free 
controls at rest, during a stressor condition, and during a post-stressor recovery period.  
The stressor condition consisted of having the participant discuss a personally relevant 
distressing experience.  Second, this study investigated factors including psychological 
distress (e.g., anxiety, depression), social-environment (e.g., social support, social 
constraints), disposition (e.g., emotion regulation), and family of origin characteristics 
that may be associated with HRV indices during the baseline, stressor, and recovery 
periods in the orofacial pain sample as compared to a pain-free matched control sample.   
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Specific Hypotheses 
1) While quietly sitting during baseline assessment, orofacial pain patients will 
have lower HF, higher LF, and higher LF/HF ratio HRV indices compared to pain-free 
controls (Porges, 1992; Thayer & Lane, 2000). 
2) During the recovery period, orofacial pain patients will have lower HF, higher 
LF, and higher LF/HF ratio HRV indices compared to pain-free controls (Porges, 1992; 
Thayer & Lane, 2000).   
3) Orofacial pain patients reporting a traumatic stressor will show very little 
change in HRV indices between baseline, stressor, and recovery (Cohen et al., 2000; 
Cohen et al., 1998). 
4) Orofacial pain patients will report more emotional reactivity to the stressor 
condition as reported on the EAS compared to pain-free controls (Curran et al., 1996; 
Maixner et al., 1995). 
5) Orofacial pain patients will report more psychological distress, sleep 
dysfunction, and fatigue than pain-free controls on self-report measures (Carlson et al., 
1998; Kight et al., 2001). 
6) Orofacial pain patients will report less social support, more social constraints, 
and a family-of-origin environment characterized by conflict and aggression, compared 
to pain-free controls (Repetti, Taylor, & Seeman, 2002).   
7) Orofacial pain patients will report use of the emotion regulation strategy of 
suppression and less use of reappraisal compared to pain-free controls (Gross & John, 
2003). 
 
 
 
 
 
 
Copyright © John E Schmidt 2006 
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Chapter 2 
Methods 
Setting and Participants 
This study was approved by the University of Kentucky Institutional Review 
Board and all participants provided written informed consent.  Study participants were 
recruited from patients seeking care at the University of Kentucky Orofacial Pain Center.  
Controls were recruited by posting flyers describing the study throughout the University 
of Kentucky Medical Center.  Controls were matched to patients on age, height, and 
weight.  All participants were recruited and completed the study between February and 
August, 2005.   
Study inclusion criteria for patients were as follows: (1) age 18 years or older; (2) 
female; (3) Research Diagnostic Criteria/Temporomandibular Disorders (RDC/TMD) 
Axis I TMD diagnosis (Dworkin and LeResche, 1992) made by a faculty member or 
resident trained in orofacial pain examination and management; (3) diagnosis of pain 
duration of at least two months; (4) current pain level of at least 3 on a 0-10 visual analog 
scale (0=no pain and 10= worst pain imaginable); (5) no past or current history of 
hypertension or heart disease; (6) not taking any cardiovascular control medication (e.g., 
beta-blockers); (7) no history of asthma or other chronic respiratory conditions; (8) no 
history of diabetes; (9) not pregnant at time of study participation; (10) prior to 
participation, resting blood pressure must meet the following criteria:  systolic blood 
pressure < 140mmHg, diastolic blood pressure < 90mmHg (Chobanian et al., 2003).  
Controls met the same criteria with the exception of items 2, 3, and 4.  In addition, 
controls had no current or past chronic pain condition (e.g., back pain, TMD, arthritis).  
All participants were compensated $40 for completion of this study. 
The participants in this study were 22 female orofacial pain patients with a mean 
age of 41.0 years (sd=12.6), a mean weight of 151.5 pounds (sd=29.3), and a mean height 
of   64.5 inches (sd=1.8).  Patients were matched to 23 pain-free controls with a mean age 
of 36.0 years (sd=11.7), a mean weight of 149.2 pounds (sd=24.1), and a mean height of 
64.8 inches (sd=2.4).    
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Design 
The study design compared patients with orofacial pain to matched pain-free 
controls on a standard set of psychometric measures and on physiological responses 
before, during, and after a laboratory challenge.  Dentists experienced in the diagnosis 
and treatment of TM disorders recruited patients during the initial diagnostic 
appointment.  Patients were then recruited by the principal investigator (PI) and 
scheduled for participation.  Control participants were matched to patients on height, 
weight, and age prior to study participation.  The laboratory challenge for all participants 
was administered by the PI. 
 
Dependent Measures 
Prior to the initial evaluation by the attending dentist, all patients completed an 
orofacial pain questionnaire that gathers demographic data, historical information 
regarding pain, a general medical history, and a battery of psychological questionnaires.  
The orofacial pain examination includes a detailed history of the patient’s chief 
complaints(s), associated symptoms, TMJ noise, mandibular dysfunction, parafunctional 
habits, past trauma, previous treatments/consultations for their chief complaint(s), as well 
as psychosocial history.  The battery of psychological questionnaires administered to 
patients included the following measures: 
Symptom Check List –90 (SCL-90).  The SCL-90-R (Derogatis, 1979) is a 90-item 
multi-dimensional self-report measure of psychological functioning scored on a five-
point scale of distress (0-4).  The specific dimensions on the SCL-90-R include 
somatization, obsessive-compulsive behavior, interpersonal sensitivity, depression, 
anxiety, hostility, phobic anxiety, paranoid ideation, and psychoticism. A global severity 
index is also available from this measure.  Test-retest reliabilities range from r=0.78 to 
0.90 for non-patient samples, and internal consistencies range from 0.77 to 0.90 
(Derogatis, 1979). 
Pittsburgh Sleep Quality Index (PSQI).  The PSQI (Buysse, Reynolds, Monk, 
Berman, & Kupfer, 1989) is a 12-item measure of sleep quality.  The PSQI gathers 
information regarding the amount of hours the patient sleeps each night, the amount of 
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hours in bed each night, how often the patient is woken up and why, as well as how 
difficult it is for the patient to return to sleep upon awakening.  The PSQI has exhibited 
test-retest stability (full scale r = 0.85), good overall internal consistency (α = 0.83), and 
provides a valid and reliable assessment of overall sleep quality and disturbance. (Buysse 
et al., 1989; Carpenter & Andrykowski, 1998). 
Posttraumatic stress disorder Check List – Civilian version (PCL-C).  The PCL-C 
(Weathers, Litz, Herman, Huska, & Keane, 1993) is a self-report measure used to assess 
the incidence of significant life stressors and prevalence of PTSD symptomatology. The 
patient first identifies significant stressors they may have experienced from a list (e.g., 
military combat, violent attack, incarceration, natural or man-made disaster, severe auto 
accident, sudden injury/serious accident, observed someone hurt or killed). The patient 
selects the most significant stressor and the notes the date of occurrence.  The patient then 
answers 17 symptom-related items by noting how much he or she has been bothered by 
each symptom in the last month.  The items are scored on a five-point Likert scale from 1 
(not at all) to 5 (extremely).  The PCL-C provides a total score as well as three subscale 
scores (reexperiencing, avoidance/numbing, and arousal).  The PCL-C has exhibited test-
retest stability (r = 0.96), good overall internal consistency (alpha = 0.92), and provides a 
valid and reliable assessment of the presence of PTSD symptoms (Blanchard et al., 
1996).  The PCL-C has demonstrated efficacy in the screening of PTSD in orofacial pain 
patients (Sherman, 1998; Sherman et al., 2005). 
Multi-dimensional Fatigue Symptom Inventory (MFSI).  The MFSI (Stein, Martin, 
Hann, & Jacobsen, 1998) is a 30-item measure designed to identify 5 facets of fatigue: 1) 
global experience of fatigue; 2) somatic symptoms of fatigue; 3) cognitive symptoms of 
fatigue; 4) affective symptoms of fatigue; and 5) behavioral symptoms of fatigue.  
Patients are asked to rate each statement according to how true it has been over the past 7 
days along a 5-point Likert scale from 0 (not at all) to 4 (Extremely). The MFSI has 
demonstrated efficacy in predicting the presence and magnitude of self-reported fatigue 
in orofacial pain patients (de Leeuw, Studts, & Carlson, 2005). 
Emotion Regulation Questionnaire (ERQ).  The ERQ (Gross & John, 2003) is a 
10-item measure designed to assess individual differences in the habitual use of two 
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emotion regulation strategies:  cognitive reappraisal and expressive suppression.  
Respondents are asked to indicate strength of agreement with each item on a seven-point 
Likert scale from 1 (strongly disagree) to 7 (strongly agree).  The ERQ has shown good 
overall internal consistency (coefficient alphas:  reappraisal = 0.79, suppression = 0.73) 
(Gross & John, 2003). 
Emotion Assessment Scale (EAS).  The EAS (Carlson et al., 1989) is a 24-item 
scale designed to measure eight fundamental dimensions of emotional responses 
(surprise, fear, disgust, anger, guilt, anxiety, sadness, and happiness).  The EAS contains 
24 visual analog scale items that range from 0 to 100 mm.  The EAS has a split-half 
reliability of .94 (Carlson et al., 1989). 
Family of Origin Scale (FOS).  The FOS (Hovestadt, Anderson, Piercy, Cochran, 
& Fine, 1985) is a 40-item measure of the perceived tone of social-emotional 
relationships in the family-of-origin, focusing on warmth and acceptance.  The 
participant is asked to indicate strength of agreement with each item on a five-point 
Likert scale from 1 (strongly disagree) to 5 (strongly agree).  The 15-item short form was 
used in this study (Ryan, Powel, Kawash, & Fine, 1995).  The FOS has shown good 
overall internal consistency (coefficient alphas:  total 40-item form=0.96, 15-item short 
form=0.95).   
Social Constraints Scale (SCS).  The SCS (Lepore & Ituarte, 1999) is a 15-item 
self-report measure of the extent to which the participant’s social environment inhibits 
expression of distressing thoughts and feelings.  This study used the “friends/family” 
version of the SCS.  The participant notes incidence of different social experiences in the 
past month using a 4-point Likert scale.  The scale ranges from “never” to “often.”  The 
test-retest reliability of the SCS is 0.71 at nine months, and coefficient alpha has ranged 
from 0.89 to 0.92 (Lepore & Ituarte, 1999). 
Duke-UNC Functional Social Support Questionnaire (DUKE-SSQ).  The DUKE-
SSQ (Broadhead, Gehlbach, De Gruy, & Kaplan, 1988) is an eight-item, 
multidimensional, functional social support questionnaire designed for use with medical 
populations.  The participant notes level of satisfaction with amount of social support in 
various areas using a 5-point Likert scale.  The scale ranges from “much less than I 
  11
would like” to “as much as I would like.”  The DUKE-SSQ yields a total score, and 
coefficient alpha has ranged from 0.86 to 0.88 (Andrykowski, Cordova, Studts, & Miller, 
1998; Schmidt & Andrykowski, 2004). 
Control participants were administered the following questionnaires:  Symptom 
Check List –90 (SCL-90), Pittsburgh Sleep Quality Index (PSQI), Posttraumatic stress 
disorder Check List – Civilian version (PCL-C), Multi-dimensional Fatigue Symptom 
Inventory (MFSI), Emotion regulation questionnaire (ERQ), Emotion Assessment Scale 
(EAS), Family of Origin Scale (FOS), Social Constraints Scale (SCS), and the DUKE-
Social Support Questionnaire (DUKE-SSQ). 
 
Current stage of menstrual cycle 
Day of menstrual cycle was recorded for participants by asking for the last day of 
their previous period.  The menstrual cycle is divided into four phases:  menstruation 
(days 1-5), proliferative phase (days 6-13), ovulation (day 14), and luteal or secretory 
phase (days 15 to 28).  Research has demonstrated that autonomic regulation of the heart 
fluctuates during the menstrual cycle with HRV being lower in the luteal phase that in the 
other phases (Landen et al., 2004; Sato, Miyake, Akatsu, & Kumashiro, 1995).  The 
results of these studies suggest that sympathetic nervous system activity is dominant 
during the luteal phase.  This difference is thought to be due to high concentrations of 
progesterone present during this phase of the menstrual cycle. 
 
Physiological measures 
The physiological measures were recorded using the MP150 Biopac data 
acquisition system (Biopac Systems, Inc.).  The configuration for this study included the 
electrocardiogram and end-tidal carbon dioxide amplifier modules.  Cardiovascular 
activity was recorded using three Ag/AgCl electrodes using shielded leads connected to 
an ECG100C electrocardiogram amplifier module.  The sampling rate for this module 
was set to 1000 samples/second.  The electrodes were placed in the Lead I configuration, 
with the positive and negative electrodes connected to the inside of the forearms (Guyton, 
1991).  Module settings were as follows:  gain = 1000; high pass filter = .05Hz; notch 
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interference filter (35Hz) = on.   
To calculate the heart rate variability frequency domain indices, the ECG signal 
was first filtered and transformed into R-R intervals using the Biopac Aquire system 
software.  These data were then saved as a text file for frequency domain analyses.  
Frequency domain analyses were completed using HRV Analysis Software version 1.1 
SP1 by Biomedical Signal Analysis Group, Department of Applied Physics, University of 
Kuoplo, Finland.  This software package is a stand-alone HRV analysis program that 
provides a variety of HRV indices including non-parametric Fast Fourier Transform 
(FFT) spectrum values of HRV, geometric HRV measures, and parametric Auto 
Regressive spectrum values of HRV.  For this study, the non-parametric FFT HRV 
values in normalized units will be reported. These include the Low Frequency (LF) 
index, the High Frequency (HF) index, and the LF/HF ratio. 
End Tidal Carbon Dioxide and breathing rate were recorded by placing a nasal 
canula under the participant’s nose.  The canule tubing was connected a CO2100C 
amplifier module.  This module records quickly varying carbon dioxide concentration 
levels, and provides a continuous measure of ETCO2 throughout the study.  Sampling 
rate for this module is 100ml/min.  The mean peak ETCO2 value was recorded as a 
percentage.  Breathing rate in breaths per minute was also recorded via the data collected 
with this module.  The only adjustable setting for this module is gain, which was set to 
5%CO2/volt for the present study.  Due to equipment problems, ETCO2 data were not 
available for all participants therefore these data will not be reported.  Breathing rate was 
successfully recorded for all study participants. 
 
Procedure 
Prior to the laboratory evaluation, participants completed an informed consent and 
were interviewed to ensure they met all screening criteria.  Height and weight were 
recorded and the participant then completed study psychometric measures in a quiet room 
free from distractions.  Once the study measures were completed, the PI introduced the 
participant to the physiological laboratory and equipment.  The participant was seated in 
a comfortable chair and the physiological recording leads were attached.  After the leads 
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were attached and tested, the participant rested quietly for a five-minute adaptation 
period.  Following this, a ten-minute baseline recording was completed (baseline period).  
During the baseline, the participant was instructed to sit quietly and was alone in the 
laboratory.  The first EAS was administered after the baseline recording.  This was 
followed by the laboratory challenge (recall period).   
The laboratory challenge consisted of having the participant describe one past 
significant stressful negative life event for ten-minutes.  Participants were encouraged not 
to ‘relive’ negative life experiences, only to describe them.  Prior to beginning the 
laboratory challenge, the PCL-C was reviewed and if a traumatic event was reported, the 
participant was asked to describe the event marked as most distressing.  If no traumatic 
event was reported on the PCL-C, the participant was asked to describe the most 
significant stressful life event experienced.  All narratives were videotaped.  The 
videotapes from this study will be analyzed and coded for a future paper.  Prior to 
describing the significant life event, a two-minute narrative trial was completed to 
acclimate the participant to the stimulus condition.  The participant was instructed to 
describe the day’s activities while facing the video camera.  During the two-minute 
acclimation and the ten-minute narrative, the participant was alone in the laboratory. 
This stimulus procedure has been used to investigate HRV differences among 
normal controls and with individuals diagnosed with PTSD and panic anxiety (Cohen et 
al., 2000; Cohen et al., 1998).  This type of procedure has also been successfully used in 
research concerning emotional expression with normals (Campbell, 2001), cancer 
patients (Graves et al., 2005), and with TMD patients (Ohrbach et al., 1998). 
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The instructions for the emotion stimulus protocol were as follows: 
 
Two-minute acclimation:  I’d like to help you get more comfortable with talking 
out loud while facing the video camera.  During the next two minutes I would like 
you to face the camera and talk about your activities for the day.  Talk about what 
you’ve already done today and what you plan on doing during the rest of the day.  
The important thing is that you describe your activities in as much detail as 
possible.  Remember to talk directly into the camera, being careful not to slouch 
down in the chair or look down at the floor.  If you find you’ve run out of things 
to say, its okay to repeat some of the things you might have said earlier.  The 
important thing is just that you try to keep talking during the whole two minutes.  
I’ll leave the room now, and then let you know when the two-minutes are up. 
 
Ten-minute narrative:  During the next 10 minutes, I want you to talk about the 
most traumatic and upsetting experience of your life.  When talking, try not to 
relive the event.  Instead, describe the event and your thoughts and feelings about 
the event.  Remember to talk directly into the camera, without slouching or 
looking down at the floor, and to talk about your thoughts and feelings about this 
traumatic and upsetting experience in your life.  If you find you’ve run out of 
things to say, its okay to repeat some of the things that you might have said 
earlier.  The most important thing is that you continue talking as much as possible 
about your thoughts and feelings about this traumatic and upsetting experience.  
You will be alone in this private room to talk about the experience, with no one 
listening to you. I will knock on the door and then enter to let you know when the 
ten-minutes are up. 
 
The laboratory challenge was followed by a ten-minute post-stressor recording 
(recovery period).  Again, the participant was alone in the room during the recording.  
This was followed by completion of another EAS.  Participants were then debriefed and 
excused from the study. 
 
 
 
 
 
 
Copyright © John E Schmidt 2006 
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Chapter 3 
Results 
Analytic Strategy 
Overall 2 (pain patients vs. matched pain-free controls) X 3 (baseline, stressor, 
and recovery) repeated measures MANOVAS were performed on the physiological and 
emotional status data.  Specific hypotheses for physiological and emotional status 
variables were tested with focused contrasts.  Hypothesized differences between the two 
groups on general psychological and social-environment variables were compared with 
univariate ANOVAs.  All statistical analyses were completed with the Statistical Package 
for the Social Sciences, Release 11.5.0.0 (SPSS Inc., 1989-2004).  The criterion for 
statistical significance was set at p < .05.  To control for Type 1 error associated with 
multiple comparisons, Bonferroni corrections were used as appropriate.  Effect sizes for 
hypothesized analyses are reported using Cohen’s d. Correlations among the main study 
variables for each group are presented in Tables 3.1 and 3.2.     
 
Pain Assessment 
Pain evaluations were completed prior to beginning the laboratory challenge to 
ensure the patients diagnosed with Masticatory Muscle Pain (MMP) were indeed 
experiencing ongoing muscle pain at the time of the study.  The MMP group reported a 
mean present pain intensity over the previous week of 53.50 (sd = 25.81) on the pain 
VAS (‘0’ to ‘100’ mm) where ‘0’ is ‘no pain at all’ and ‘100’ is ‘the worst pain 
imaginable.’  The Pain Free Control (PFC) group reported no chronic pain condition or 
present pain complaint at the time of study participation.   
 
Current stage of menstrual cycle 
Prior to the completing the physiological analyses, the two groups were compared 
on phase of menstrual cycle during time of study participation.  This comparison was 
done to ensure there was an equal distribution of participants in the luteal phase between 
the groups at the time of study completion.  A Chi-square comparison was completed and 
  16
showed no significant difference in the number of participants in the luteal phase, MMP 
= 6 vs. PFC = 3; chi-square (1,44) = 1.42, p < .30. 
 
Incidence and Severity of Traumatic Stressors 
The two groups were compared on number of participants that reported a 
traumatic stressor and met criteria for clinically significant PTSD symptomatology 
according to the cut-off score established by Blanchard et al. (1996).  A Chi-Square 
comparison between the two groups was completed and showed no significant difference 
in the number of participants reporting a significant stressor on the PCL-C, MMP = 14 
vs. PFC = 11; chi-square (1,44) = 1.13, p < .30. These two sub-groups were compared on 
the PCL-sum score to determine if there was a significant difference in reported PTSD 
symptom intensity. Results showed no significant difference between the two sub-groups 
on PCL-sum score, MMP = 35.14 vs. PFC = 31.18; F(1,24) = .79, p < .40. The number of 
participants that met the cut-off score for clinically significant PTSD symptomatology 
was n = 5 (23%) for the MMP group and n = 1 (4%) for the PFC group.   
 
Physiological Variables 
The overall MANOVA for HRV indices indicated no significant main effect for 
group differences between the MMP group and PFC group, Wilks’ Lambda (3,41) = .86, 
p < .10.  Results showed a significant main effect for time, Wilks’ Lambda (6,38) = .38, p 
< .001.  Pairwise comparisons among the HRV indices across the three study time 
periods showed significant differences between the baseline and recall periods (LF 
baseline = 55.45, recall = 74.23, p < .001; HF baseline = 44.55, recall = 25.34, p < .001; 
Ratio baseline = 1.55, recall = 4.06, p < .001) and the recall and recovery periods (LF 
recall = 74.23, recovery = 59.07, p < .001; HF recall = 25.34, recovery = 41.55, p < .001; 
Ratio recall = 4.06, recovery = 1.96, p < .001).  These data confirm the effectiveness of 
the stress recall procedure used in this study.  There was no main effect for the interaction 
of time x group, Wilks’ Lambda (6,38) = .87, p < .10.   
The overall MANOVA was followed by focused contrasts to evaluate the a priori 
hypothesis that the MMP group would have lower HF, higher LF, and higher LF/HF ratio 
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HRV indices at baseline compared to the PFC group.  Focused contrasts showed 
marginally significant differences in the LF and HF baseline HRV values with the MMP 
group higher on LF HRV, MMP = 60.11 vs. PFC = 51.18, F(1,44) = 3.86, p < .06, 
Cohen’s d = .59, and lower on HF HRV, MMP = 39.89 vs. PFC = 48.82, F(1,44) = 3.86, 
p < .06, Cohen’s d = .59, when compared to the PFC group.  As expected the LF/HF 
baseline value was significantly higher in the MMP group, MMP = 1.97 vs. PFC = 1.16, 
F(1,44) = 9.17, p < .01, Cohen’s d = .90, when compared to the PFC group.    
To evaluate the a priori hypothesis that the MMP group will have higher LF, 
lower HF, and higher LF/HF ratio HRV indices at recovery compared to the PFC group, 
univariate comparisons between the experimental groups were completed on these HRV 
indices.  Results showed the MMP group to be significantly higher on LF compared to 
the PFC group, MMP = 63.87 vs. PFC = 54.96, F(1,44) = 4.30, p < .05, Cohen’s d = .62, 
significantly lower on HF compared to the PFC group, MMP = 36.13 vs. PFC = 46.49, 
F(1,44) = 6.11, p < .056, Cohen’s d = .74, and significantly higher on the LF/HF ratio 
compared to the PFC group, MMP = 2.72 vs. PFC = 1.26, F(1,44) = 6.47, p < .05, 
Cohen’s d = .75.  Characteristics of the HRV indices are presented in Table 3.3.  Figures 
3.1, 3.2, and 3.3 provide graphical displays of the LF, HF, and LF/HF ratio HRV indices 
group differences across study periods. 
To determine if the differences were due to initial baseline differences between 
the groups, Analyses of Covariance (ANCOVA) using the initial baseline values as the 
covariate were completed for the recall and recovery period HRV indices.  No differences 
were found between the two groups on recall or recovery period HRV indices when 
baseline values were used as covariates.  These results of the ANCOVA analyses are 
presented in Table 3.4.   
A 1 (stressor) X 3 (baseline, stressor, recovery) repeated measures analyses of 
variance was used to evaluate the hypothesis that participants in the MMP group 
reporting a traumatic stressor will show very little change in HRV indices between the 
three recording periods.  Of the 22 MMP participants in this study, 14 (64%) reported a 
traumatic stressor.  The overall MANOVA for the HRV indices indicated no significant 
main effect for time, Wilks’ Lambda (2,12) = .52, p < .20.  Repeated measures univariate 
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analyses were significant for LF HRV [F(2,12) = 6.40, p < .05, HF HRV, F(2,12) = 6.40, 
p < .01, and LF/HF ratio,  F(2,12) = 7.26, p < .01 across the three study periods.  Within-
subject focused contrasts showed a significant difference between the baseline and recall 
periods for all HRV indices, however, there were no significant differences between the 
recall and recovery periods on the HRV indices.  The HRV means and standard 
deviations for the MMP patients that reported a traumatic stressor are shown presented in 
Table 3.5. 
Breathing rates in breaths-per-minute were also recorded and calculated for each 
period.  Univariate comparisons between groups for the baseline, MMP = 18.8 vs. PFC = 
16.4, F(1,44) = 2.57, p < .200, and recovery periods, MMP = 18.2 vs. PFC = 15.6, 
F(1,44) = 3.33, p < .10, showed no significant difference in breathing rates between the 
two experimental groups. 
 
Emotional Reactivity  
Emotional status was assessed immediately following the baseline period and 
again, after the recovery period.  All study participants completed the EAS at these time-
points.  The overall 2 (group) X 2 (baseline vs. recovery) MANOVA on the emotional 
reactivity variables indicated a significant difference between the MMP and PFC groups, 
Wilks’ Lambda (16,27) = .245, p<001.  To evaluate the hypothesis that the MMP group 
would report more emotional reactivity to the stressor period compared to the PFC group, 
univariate comparisons were completed on the emotional status variables.  The MMP 
group reported more ‘anxiety’ prior to the stressor, MMP = 25.0 vs. PFC = 11.0, F(1,43) 
= 4.35, p < .05, Cohen’s d = .62, and more ‘anger’ after the recovery period, MMP = 
11.18 vs. PFC = 2.74, F(1,43) = 5.87, p < .05, Cohen’s d = .72,  compared to the PFC 
group.  In contrast, the PFC group reported more ‘happiness’ prior to the stressor, MMP 
= 25.6 vs. PFC = 42.8, F(1,43) = 4.09, p < .05, Cohen’s d = .60, than did the MMP group.   
 
Psychological, physical, and social Variables 
The between groups MANOVA on the psychological, fatigue, and sleep variables 
indicated a significant difference between the MMP group and PFC group, Wilks’ 
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Lambda (15,29) = .152, p < 001.  To evaluate the hypothesis that the MMP group would 
report more psychological distress compared to the PFC group, a univariate comparison 
was completed on the Global Severity Index (GSI) of the SCL-90-R.  The MMP group 
scored significantly higher on the GSI, F(1,44) = 16.69, p < .001, Cohen’s d = 1.22, 
compared to the PFC group.  This analysis was followed by post-hoc comparisons on the 
individual SCL-90-R subscales using Bonferroni corrections to control for Type 1 error.  
The MMP group reported greater somatization, F(1,44) = 44.71, p < .001, Cohen’s d = 
2.0, obsessive-compulsive behavior, F(1,44) = 7.74, p < .01, Cohen’s d = .81, depression, 
F(1,44) = 10.03, p < .01, Cohen’s d = .95, and anxiety, F(1,44) = 7.54, p < .01, Cohen’s d 
= .82 on the SCL-90-R subscales as compared to the PFC group.  To evaluate the 
hypothesis that the MMP group would report more fatigue compared to the PFC group, 
univariate comparisons were made on the subscales of the MFSI.  The MMP group 
reported significantly more general fatigue, F(1,44) = 13.56, p < .001, Cohen’s d = 1.22, 
physical fatigue, F(1,44) = 32.99, p < .001, Cohen’s d = 1.74,  and mental fatigue, 
F(1,44) = 12.87, p < .001, Cohen’s d = 1.01, than the PFC group.  The MMP group also 
reported significantly less vigor F(1,44) = 11.72, p < .001, Cohen’s d = 1.02, compared to 
the PFC group.  As hypothesized, the MMP group reported more sleep dysfunction 
compared to the PFC group, F(1,44) = 56.88, p < .001, Cohen’s d = 2.0.  These data are 
presented in Table 3.6.  
To evaluate the hypothesis that the MMP group would report more social 
constraints, less social support, and a family-of-origin environment characterized by 
conflict and aggression when compared to the PFC group, univariate comparisons were 
completed on these variables.  A significant difference was found on perceived social 
constraints, SCS: F(1,44) = 7.40, p < .01, Cohen’s d = .78, with the MMP group reporting 
a more constraining social environment than did the PFC group.  In contrast, no 
difference was noted between the two groups on perceived social support, DUKE-SSQ:  
F(1,44) = .08, p < .80.  The MMP group also reported a more dysfunctional family-of-
origin, FOS:  F(1,44) = 4.46, p < .05, Cohen’s d = .65, compared to the PFC group.  
These results are presented in Table 3.7.   
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To test the hypotheses that the MMP group would report more use of the emotion 
regulation strategy of reappraisal and less use of suppression compared to the PFC group, 
univariate comparisons were completed on these two variables.  The two groups were not 
significantly different on the measured emotion regulation strategies of reappraisal, ERQ-
Reappraisal:  F(1,44) = .93, p < .40, or suppression, ERQ-Suppression:  F(1,44) = .04, p 
< .900.  These data are presented in Table 3.7 as well. 
A post-hoc comparison on social environment measures was then completed 
among the participants in the MMP group who reported a traumatic stressor.  Results 
showed that the MMP group participants reporting clinically significant PTSD 
symptomatology reported significantly higher perceived social constraints, MMP(PTSD-
positive) = 43.0 vs. MMP(PTSD-negative) = 29.6; F(1,13) = 6.33, p < .05, Cohen’s d = 
1.5, and lower perceived social support, MMP (PTSD-positive) = 23.2 vs. MMP (PTSD-
negative) = 33.1; F(1,13) = 8.78, p < .05, Cohen’s d = 1.8, compared to the MMP group 
participants who reported a traumatic stressor, but did not meet the cut-off for clinically 
significant PTSD symptomatology. There were no differences on the Family of Origin 
measure between these two sub-groups of patients, MMP (PTSD-positive) = 41.7 vs. 
MMP (PTSD-negative) = 38.0; F(1,13) = .25, p < .700. 
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 Measure                
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
1. LF/HF-B 1.0               
2. LF/HF-R .555* 1.0              
3. VAS -.351 -.294 1.0             
4. Duration .219 .191 .311 1.0            
5. PSQI .178 .372 .264 -.167 1.0           
6. SCS -.538* -.223 .710** .335 -.188 1.0          
7. DUKE .736* .329 -.624* -.031 -.110 -.717* 1.0         
8. ERQ-R -.227 -.226 -.198 -.011 -.176 .306 -.219 1.0        
9. ERQ-S -.057 -.252 .617 .209 -.016 .340 -.258 -.022 1.0       
10. FOS .371 .208 -.777** -.165 .153 -.604* .496 -.266 -.318 1.0      
11. GSI -.285 .010 .447 .082 .432 .486 -.495 -.068 .213 -.221 1.0     
MFSI                
12. General -.437 -.192 .550 .095 .439 .373 -.499 -.275 .163 -.404 .505 1.0    
13. Emotion -.230 .050 .647 .121 .541* .500 -.454 -.102 .334 -.251 .850* .600* 1.0   
14. Physical -.354 -.101 .622 .347 .419 .591* -.682* .039 .298 -.346 .820* .565* .775* 1.0  
15. Mental -.122 .082 .359 .156 .472 .368 -.358 .162 .206 -.096 .827* .337 .637* .585* 1.0 
16. Vigor .041 -.123 -.290 -.385 -.460 -.208 .178 .261 -.203 .073 -.326 -.615* -.584* -.423 -.161 21 * correlation is significant at the .01 level. 
Note.  LF/HF=Low Frequency to High Frequency HRV Ratio (B=Baseline, R=Recovery).  VAS=Visual Analog Scale of 
present pain. Duration=Duration of pain.  PSQI=Pittsburgh Sleep Quality Index.  SCS=Social Constraints Scale.  DUKE-SSQ:  
Duke Social Support Questionnaire.  ERQ-R=Emotion Regulation Questionnaire-Reappraisal.  ERQ-S=Emotion Regulation 
Questionnaire-Suppression.  FOS=Family of Origin Scale. GSI=General Severity Index of the SCL-90R. 
MFSI=Multidimensional Fatigue Symptom Inventory. 
 
Table 3.1 
Intercorrelations Between Major Independent Variables with Dependent Variables for the Muscle Pain Patients.  (N = 22) 
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Measure              
 1 2 3 4 5 6 7 8 9 10 11 12 13 
1. LF/H  F-B 1.0             
2. LF/HF-R .244 1.0            
3. PSQI -.112 -.118 1.0           
4. SCS .458 .035 .232 1.0          
5. DUKE -.449 -.081 .035 -.689* 1.0         
6. ERQ-R -.443 -.065 -.097 -.313 .427 1.0        
7. ERQ-S -.019 .144 .006 .349 -.351 -.117 1.0       
8. FOS -.245 .278 .013 -.476 .565* .259 .130 1.0      
9. GSI .205 .160 .343 .539* -.556* .357 .495* -.300 1.0     
M  FSI              
10. General .006 .202 .454 .174 -.174 -.226 .460* .070 .682* 1.0    
11. Emotion .136 .155 .352 .376 -.353 -.156 -.055 -.349 .545* .412 1.0   
12. Physical -.105 -.005 -.126 .213 -.157 -.190 .385 -.053 .490 .397 .112 1.0  
13. Mental .176 .465 .257 .198 -.415 -.279 .554* -.088 .658* .789* .310 .191 1.0 
14. Vigor -.156 .039 .228 -.176 .554* .297 -.234 .140 -.381 .018 -.095 -.175 -.068 
* correlation is significant at the .01 level. 
Note.  LF/HF=Low Frequency to High Frequency HRV Ratio (B=Baseline, R=Recovery).  VAS=Visual Analog Scale of 
present pain. Duration=Duration of pain.  PSQI=Pittsburgh Sleep Quality Index.  SCS=Social Constraints Scale.  DUKE-SSQ:  
Duke Social Support Questionnaire.  ERQ-R=Emotion Regulation Questionnaire-Reappraisal.  ERQ-S=Emotion Regulation 
Questionnaire-Suppression.  FOS=Family of Origin Scale. GSI=General Severity Index of the SCL-90R. 
MFSI=Multidimensional Fatigue Symptom Inventory. 
 
 
Table 3.2 
Intercorrelations Between Major Independent Variables with Dependent Variables for the Pain Free Controls.  (N = 23) 
 Table 3.3 
Characteristics of Heart Rate Variability Indices 
 
 Pain Group 
(n=22) 
M (sd) 
Control Group 
(n=23) 
M (sd) 
F(1,44) p Cohen’s d 
Baseline      
     LF (nu) 60.11 
(17.92) 
51.18 
(11.89) 
3.86 .056 .59 
     HF (nu) 39.89 
(17.92) 
48.82 
(11.89) 
3.86 .056 .59 
     LF/HF 1.97 
(1.16) 
1.16 
(.52) 
9.17 .004 .90 
Recall      
     LF (nu) 74.65 
(14.80) 
73.83 
(12.36) 
.04 .843 .06 
     HF (nu) 24.44 
(12.27) 
26.17 
(12.36) 
.22 .646 .14 
     LF/HF 4.40 
(3 37)
3.76 
(2 36)
.53 .470 .16 
Recovery      
     LF (nu) 63.87 
(16.61) 
54.69 
(12.66) 
4.30 .044 .62 
     HF (nu) 36.13 
(16.61) 
46.49 
(10.82) 
6.11 .018 .74 
     LF/HF 2.72 
(2 71)
1.26 
( 49)
6.47 .015 .75 
Note. LF (nu) = Low Frequency (normalized units), HF (nu) = High Frequency 
(normalized units), LF/HF = Low Frequency to High Frequency ratio.  Cohen’s d notes 
effect sizes for significant contrasts. 
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 Table 3.4 
ANCOVA Results for Heart Rate Variability Indices  
 
 Pain Group 
(n=22) 
M (sd) 
Control Group 
(n=23) 
M (sd) 
F(1,44) P 
Recall     
     LF (nu) 
74.65 
(14.80) 
73.83 
(12.36) 
.07 .793 
     HF (nu) 
24.44 
(12.27) 
26.17 
(12.36) 
.00 .985 
     LF/HF 4.40 (3.37) 
3.76 
(2.36) 
.00 .987 
Recovery     
     LF (nu) 
63.87 
(16.61) 
54.69 
(12.66) 
1.02 .318 
     HF (nu) 
36.13 
(16.61) 
46.49 
(10.82) 
2.26 .140 
     LF/HF 2.72 (2.71) 
1.26 
(.49) 
1.07 .308 
Note. Baseline values for HRV indices were used as covariates for these data.  LF (nu) = 
Low Frequency (normalized units), HF (nu) = High Frequency (normalized units), LF/HF 
= Low Frequency to High Frequency ratio. 
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 Table 3.5 
Characteristics of Heart Rate Variability Indices in MMP Patients Reporting a Trauma 
 
 
Baseline Recall Recovery 
MMP reporting  
a trauma 
(n=14) 
   
LF (nu) 
59.15a 
(18.27) 
77.18 b 
(13.43) 
 
64.37 b 
(17.25) 
HF (nu) 
40.85 a 
(18.28) 
22.81 b 
(13.43) 
35.63 b 
(17.25) 
LF/HF 
1.91 a 
(1.19) 
5.17 b 
(4.01) 
3.07 b 
(3.33) 
Note. Means and standard deviations are shown.  LF (nu) = Low Frequency (normalized 
units), HF (nu) = High Frequency (normalized units), LF/HF = Low Frequency to High 
Frequency ratio. 
ab When superscripts are the same between the periods on a measure, focused contrasts 
indicate no significant difference in period  means. When superscripts are different, 
focused contrasts indicate significant difference between period means at p < .05.   
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 Table 3.6 
SCL-90-R Symptom Dimension, Fatigue, and Sleep Quality Means and Standard 
Deviations 
 
 Pain Group 
(n=22) 
M (sd) 
Control Group 
(n=23) 
M (sd) 
F(1,44) p Cohen’s d
General Severity 
Index (GSI) 
64.55 
(6.89) 
54.26 
(9.69) 
16.69 .001 1.22 
Somatization 67.95 
(7.56) 
50.48 
(9.78) 
44.71 .001 2.00 
Obsessive-
compulsive 
63.23 
(10.56) 
54.39 
(11.24) 
7.74 .009 .81 
Interpersonal 
Sensitivity 
58.73 
(9.07) 
56.78 
(11.55) 
.39 .534 .19 
Depression 63.36 
(5.67) 
56.04 
(9.32) 
10.03 .003 .95 
Anxiety 59.14 
(11.13) 
50.48 
(10.02) 
7.54 .009 .82 
Hostility 55.91 
(10.46) 
50.91 
(7.12) 
3.54 .067 .56 
Phobic anxiety 56.09 
(11.75) 
50.87 
(8.77) 
2.87 .097 .80 
Paranoid 
ideation 
57.41 
(11.48) 
50.43 
(11.79) 
4.03 .051 .60 
Psychoticism 59.09 
(11.45) 
55.74 
(11.56) 
.95 .334 .29 
MFSI      
General 
Fatigue 
16.77 
(8.96) 
6.68 
(7.52) 
13.56 .001 1.22 
Emotional  
Fatigue 
9.91 
(5.99) 
6.96 
(4.90) 
3.27 .077 .54 
Physical 
Fatigue 
11.95 
(3.22) 
6.73 
(2.76) 
32.99 .001 1.74 
Mental 
Fatigue 
8.59 
(5.37) 
3.65 
(3.76) 
12.87 .001 1.01 
Vigor 8.91 
(4.45) 
12.91 
(3.34) 
11.72 .001 1.02 
PSQI 11.36 
(3.54) 
4.70 
(2.29) 
56.88 .001 2.00 
Note. SCL-90-R = Symptom CheckList 90 – Revised, MFSI = Multidimensional Fatigue 
Symptom Inventory, PSQI = Pittsburgh Sleep Quality Index.   
Cohen’s d notes effect sizes for significant contrasts. 
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 Table 3.7 
Characteristics of Self-Report Psycho-Social Domain Measures 
 Pain Group 
(n=22) 
Control Group 
(n=23) 
F(1,44) p Cohen’s d 
Measure  M (sd) M (sd)    
SCS 34.33 
(11.95) 
26.00 
(9.26) 
7.40 .009 .78 
      
DUKE-SSQ 30.62 
(7.05) 
31.27 
(8.19) 
.08 .779 .09 
      
Family of Origin 42.48 
(12.58) 
50.09 
(11.32) 
4.46 .041 .65 
      
ERQ-
Reappraisal 
31.33 
(5.20) 
29.65 
(5.84) 
.93 .341 .30 
      
ERQ-
Suppression 
12.86 
(3.77) 
12.35 
(4.67) 
.04 .851 .12 
Note. PSQI = Pittsburgh Sleep Quality Index, SCS = Social Constraints Scale, DUKE-
SSQ – DUKE Social Support Questionnaire, ERQ = Emotion Regulation Questionnaire, 
MFSI = Multidimensional Fatigue Symptom Inventory.  Cohen’s d notes effect sizes for 
significant contrasts. 
 
 27
  28
Figure 3.1 
Low Frequency (nu) HRV 
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Note: *p<.06 between group comparison marginally significant at the baseline period.  
**p<.05 between group comparison significant at the recovery period.
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Figure 3.2 
High Frequency (nu) HRV 
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Note: *p<.06 between group comparison marginally significant at the baseline period. 
**p<.05 between group comparison significant at the recovery period.  
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Figure 3.3 
Low Frequency to High Frequency Ratio (LF/HF) 
 
 
0
1
2
3
4
5
Baseline Recall Recovery
MMP Group PFC Group
 
*
 
*
 
 
 
 
 
 
Note: *p<.05 between group comparisons significant at the baseline and recovery 
periods.    
 
 Chapter 4 
Discussion 
This study compared a group of chronic masticatory muscle pain patients with a 
group of age, height, and weight matched pain-free controls on emotional and 
physiological reactivity to a personally relevant stressor. The main aim of this study was 
to determine the efficacy of using heart rate variability indices as quantitative measures 
of autonomic regulation that would differentiate chronic masticatory muscle pain patients 
from matched pain-free controls.  One of the noteworthy findings from this study was 
that muscle pain patients showed significantly higher LF, LF/HF ratio, and lower HF 
HRV indices during recovery from a personally relevant stressor compared to the pain-
free controls.  During the stressor period the HRV index values were nearly the same for 
both study groups.   
The physiological differences shown by the HRV indices between muscle pain 
patients and pain-free controls during the recovery period helps us understand previous 
findings of heightened physiological activation with these patients.  Masticatory muscle 
pain patients have shown more cardiovascular and emotional reactivity to a standard 
stressor when compared to controls (Carlson et al., 1998; Curran et al., 1996).  Muscle 
pain patients have also consistently shown lower pain threshold and tolerance when 
compared to pain-free controls (Carlson et al., 1998; Maixner et al., 1995; Maixner, 
Fillingim, Sigurdsson, Kincaid, & Silva, 1998).  While pain-sensitivity differences are 
likely due to a complex integration of central nervous system changes, these differences 
also could be linked to chronic physiological activation that does not respond to 
inhibitory controls. The HRV differences between muscle pain patients and pain-free 
controls in the present study suggest potential use of HRV indices as a means to study the 
relative contributions of sympathetic and parasympathetic activity.  Furthermore, the 
nearly significant increased sympathetic activity and decreased parasympathetic activity 
noted in the muscle pain patients at rest in this study as compared to the pain-free 
controls raises the possibility that these patients may be experiencing compromised 
inhibitory control of sympathetic activity.  
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 Heart rate variability as an index of autonomically-mediated inhibitory control is 
central to Thayer’s model of neurovisceral integration (Thayer & Lane, 2000).  Within 
the framework of this model, Thayer proposed that the measurement of HRV may 
quantify self-regulatory ability.  Specifically, higher vagal tone as indexed by higher HF 
HRV is associated with enhanced self-regulatory ability through greater behavioral 
flexibility and adaptability.  Poor HRV, as indexed by higher LF and lower HF HRV, is 
associated with poor self-regulation and a lack of behavioral flexibility (Porges, 1992; 
Thayer & Lane, 2000).  Thayer’s model posits that a reduction in overall system 
flexibility results from disinhibition of sympathetic nervous system activity.  The data 
presented here provide evidence of such sympathetic disinhibition in chronic muscle pain 
patients. Higher LF and lower HF index values in the muscle pain patients during the 
baseline and recovery periods compared to pain-free controls suggest diminished 
inhibitory control both at rest and after a stressor.  This pattern of physiological activation 
indexed by HRV measures has been associated with not only other chronic pain 
conditions, but other negative life experiences as well (Thayer & Lane, 2002).  
It is not surprising, therefore, that patients reporting a traumatic stressor could not inhibit 
sympathetic activation during the recovery period.  As we hypothesized, the HRV values 
during the recovery period were similar to HRV values during the stressor period for 
these patients.  The high LF and low HF HRV index values in this group of muscle pain 
patients during recovery suggest an inability to inhibit sympathetic activity.  Previous 
studies exploring hyperarousal in PTSD patients also have demonstrated a basal state of 
autonomic activation characterized by pronounced sympathetic activity, followed by no 
significant inhibitory activity of sympathetic tone after recounting traumatic events or 
after discussion of the traumatic experience linked to the onset of PTSD (Cohen et al., 
2000; Cohen et al., 1998).  The lack of variability in autonomic activity in PTSD patients 
in these studies suggests a prolonged activation of the sympathetic nervous system.  
Although the muscle pain patients reporting a traumatic experience in the present study 
did respond to discussing the event with an increase in LF and a decrease in HF HRV 
indices, these patients also had sustained physiological arousal between the stressor and 
recovery periods.  The differences between results found by Cohen and the present study 
may be due mainly to patient characteristics.  The patient volunteers in Cohen’s studies 
 32
 were all diagnostically classified with PTSD and were being treated on an outpatient 
basis for this disorder.  In contrast, only 23% of the patients reporting a traumatic event in 
this study met the cut-off for clinically significant PTSD symptomatology.  Thus it is not 
surprising that physiological activation in the muscle pain patients was not as pronounced 
as is found in those with a diagnosis of PTSD. 
The HRV characteristics of the muscle pain patients across study periods suggest 
the problem is not in reaction to a stressor per se, but more likely a problem of prolonged 
sympathetic activation stemming from inhibitory failure, or a failure of recovery 
following exposure to stressors.  Since the muscle pain patients also reported more 
anxiety after the baseline period and more anger after the recovery period compared to 
the pain-free controls, it may be that emotional reactivity is contributing to the elevated 
level of physiological functioning found in the muscle pain patients as compared to the 
pain-free controls.  The presence of more emotional reactivity in the muscle pain patients 
suggests that emotion regulation may be a factor.  These results are in contrast to Carlson 
et al (1998), who did not report any differences on emotional reactivity between 
masticatory muscle pain patients and matched controls at baseline or after a standard 
stressor.  On the other hand, use of a personally relevant stressor, in this case discussing a 
distressing or traumatic life experience, may account for this difference.  While the 
change in HRV indices between the baseline and recall periods for both the muscle pain 
patients and the pain-free controls indicate the emotional stressor did in fact significantly 
influence autonomic system functioning through emotional arousal, the patients reported 
more emotional reactivity both prior to and after the stressor.  In Thayer’s model of 
neurovisceral integration (Thayer & Lane, 2000), the inability to inhibit sympathetic 
activity has been associated with a defensive attentional style characteristic of anxiety, 
hyperarousal, and poor emotion regulation capabilities.  These characteristics may also be 
present to some degree in chronic muscle pain patients and be contributing to the 
prolonged physiological activation. 
Consistent with previous literature focused on psychological distress in muscle 
pain patients, the SCL-90 results also suggest a problem with persistent emotional 
turmoil and poor emotional processing.  The psychological distress in these patients may 
be the result of an emotion regulation deficiency, pre-morbid psychopathology, a long-
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 term problem due to an antagonistic and unloving family-of-origin environment, or a 
combination thereof.  Regardless of the source, problems in the social environment, as 
shown by the presence of social constraints in the muscle pain patients, suggests 
insufficient opportunities for cognitive processing of distress-related information.  This is 
consistent with social-cognitive processing theory (Lepore, 2001; Lepore & Helgeson, 
1998) which posits that trauma-related distress may remain elevated if the individual fails 
to engage in suitable discussion of thoughts and feelings regarding the traumatic 
experience. Such failure may occur due to the lack of ability to express trauma-related 
thoughts and feelings (e.g., alexithymia).  A failure to discuss trauma-related thoughts 
and feelings may also be due to a social environment that is constraining, where the 
individual’s attempts at discussion are met with unexpected or negative responses from 
others.   Discussion and processing of trauma-related thoughts and feelings in a non-
constraining social environment, on the other hand, provides opportunities for the 
individual to confront and reevaluate thoughts and feelings so that this information can be 
integrated into preexisting mental schemas.     
 There is conflicting evidence in the literature about the etiology and mechanisms 
involved in maintenance of muscle pain conditions.  For example, some evidence 
suggests alterations in central processing structures maintain these conditions (Maixner et 
al., 1995; Maixner, Fillingim, Kincaid, Sigurdsson, & Harris, 1997; Maixner et al., 1998).  
This central nervous system change may be due to alterations in baroreceptor effects, 
which in turn are influenced by arterial blood pressure changes (Maixner et al., 1998).  
There is also evidence to support the pain-adaptation model (Graven-Nielsen, Svensson, 
& Arendt-Nielsen, 1997), which proposes chronic pain arises from increases in muscle 
activity in antagonist musculature structures.  This increase in antagonist muscle 
structures is likely a functional adaptation of muscle coordination to limit muscle activity 
at the site of pain (Lund, 1991).  In general, however, the evidence that over-activation of 
muscle structures as a driving mechanism for chronic muscle pain is not consistent 
(Ohrbach & Dworkin, 1998).  The present study suggests that a failure of inhibitory 
control of sympathetic activation may be influencing central processing, as well as 
physiological changes in peripheral structures.   
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 The data presented here suggest the use of HRV frequency analyses can be 
helpful in identifying muscle pain patients with chronic autonomic arousal.  The HRV 
indices are consistent and stable biomarkers for sympathetic activation and inhibitory 
failure.  More importantly, HRV frequency indices demonstrate the ability to differentiate 
among muscle pain patients with traumatic experiences and those without such 
experiences.  There is also potential application of these quantitative markers for 
evaluating the effects of the treatment of chronic masticatory muscle pain patients.  
Techniques that conceivably strengthen sympathetic inhibitory control through increasing 
vagal tone should lead to an improvement in HRV indices, increased parasympathetic 
tone, improved inhibition of sympathetic activation, and possible changes in 
psychophysiological response to environmental challenge.  Carlson and colleagues have 
developed a Physical Self-Regulation Training protocol for chronic orofacial pain 
patients that includes components tailored to reduce physiological activation through the 
use of diaphragmatic breathing training, gentle stretching exercises, and proprioceptive 
awareness training (Carlson, Bertrand, Ehrlich, Maxwell, & Burton, 2001).  While the 
effect of these interventions on HRV indices have yet to be evaluated, the physiological 
activation differences between the muscle pain patients and pain-free controls in the 
present study suggest such self-regulatory skills training improves inhibitory control of 
sympathetic activity.  Indeed, recent work by Lehrer and colleagues has shown that 
biofeedback training using HRV indices resulted in increased vagal tone and 
parasympathetic arousal as well as an increase in baroreflex gain (Lehrer et al., 2003).   
 
Limitations  
While the results of this study are potentially very important, several limitations 
must be noted.  Although the experimental design lays the essential foundation for 
determining between-group differences, nearly significant baseline group differences on 
the HRV indices make it difficult to establish definitively the problem of recovery after 
the stressor.  Recovery from events that provoke sympathetic activity in pain patients thus 
remains an open question that requires further study.  Additionally, the sample size in this 
study is small and only includes women.  There is also evidence of gender differences in 
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 HRV measures (Carter et al., 2003).  These limitations suggest the need for replication of 
this study, and broader evaluation of HRV characteristics in orofacial pain patients.  
The Emotion Regulation Questionnaire did not demonstrate differences between 
the groups on the emotion regulation strategies of suppression or reappraisal.  This result 
may be due to no differences between the groups on these emotion regulation strategies.  
However, it may also be due to a measurement issue with this population or with the self-
report instrument itself.  The psychological data in this study and in previous studies 
suggest that emotion regulation is an important issue for MMP patients.  Future studies 
should consider more focused measures of emotion regulation to investigate associations 
between that construct and other characteristics of patients with orofacial pain conditions. 
 
Summary  
In summary, the present study provides evidence of physiological activation and 
emotional responding to a personally-relevant stressor in masticatory muscle pain 
patients that differentiates them from matched pain-free controls.  The use of HRV 
indices to measure physiological functioning quantifies the degree of sympathetic and 
parasympathetic activity.  The results suggest the use of these HRV indices will improve 
understanding of the role that excitatory and inhibitory mechanisms play in the onset and 
maintenance of chronic masticatory muscle pain conditions. 
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 Appendix 
Pittsburgh Sleep Quality Index (PSQI) 
 
Name__________________________ ID#_________ Date________ Age___________ 
 
Instructions: 
The following questions relate to your usual sleep habits during the past month ONLY. Your 
answers should indicate the most accurate reply for the majority of days and nights in the past 
month. Please answer all questions. 
 
1. During the past month, when have you usually gone to bed at night? 
 
USUAL BED TIME_________________________ 
 
2. During the past month, how long (in minutes) has it usually taken you to fall asleep each 
night? 
 
NUMBER OF MINUTES_____________________ 
 
3. During the past month, when have you usually gotten up in the morning? 
 
USUAL GETTING UP TIME__________________ 
 
4. During the past month, how many hours of actual sleep did you get at night? (This may 
be different than the number of hours you spend in bed.) 
 
HOURS OF SLEEP PER NIGHT________________ 
 
For each of the remaining questions, check the one best response. Please answer all questions. 
 
5. During the past month, how often have you had trouble sleeping because you…….. 
 
(a) cannot get to sleep within 30 minutes 
 
Not during the Less than Once or Three or more 
past month________ once a week_______ twice a week_______ times a week______ 
 
(b) Wake up in the middle of the night or early morning 
 
Not during the Less than Once or Three or more 
past month________ once a week_______ twice a week_______ times a week______ 
 
(c) Have to get up to use the bathroom. 
 
Not during the Less than Once or Three or more 
past month________ once a week_______ twice a week_______ times a week______ 
 
(d) Cannot breathe comfortably. 
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 Not during the Less than Once or Three or more 
past month________ once a week_______ twice a week_______ times a week______ 
 
(e) Cough or snore loudly. 
 
Not during the Less than Once or Three or more 
past month________ once a week_______ twice a week_______ times a week______ 
 
(f) Feel too cold. 
 
Not during the Less than Once or Three or more 
past month________ once a week_______ twice a week_______ times a week______ 
 
(g) Feel too hot. 
 
Not during the Less than Once or Three or more 
Past month________ once a week_______ twice a week_______ times a week______ 
 
(h) Had bad dreams. 
 
Not during the Less than Once or Three or more 
Past month________ once a week_______ twice a week_______ times a week______ 
 
(i) Have pain. 
 
Not during the Less than Once or Three or more 
Past month________ once a week_______ twice a week_______ times a week______ 
 
(j) Other reason(s), please describe_____________________________________ 
page 
How often during the past month have you had trouble sleeping because of this? 
 
Not during the Less than Once or Three or more 
Past month________ once a week_______ twice a week_______ times a week______ 
 
6. During the past month, how would you rate your sleep quality overall? 
 
Very good _____________ 
Fairly good _____________ 
Fairly bad _____________ 
Very bad _____________ 
 
7. During the past month, how often have you taken medicine (Prescribed or "over the 
counter") to help you sleep? 
 
Not during the Less than Once or Three or more 
Past month________ once a week_______ twice a week_______ times a week______ 
 
8. During the past month, how often have you had trouble staying awake while driving, 
eating meals, or engaging in social activity? 
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 Not during the Less than Once or Three or more 
Past month________ once a week_______ twice a week_______ times a week______ 
 
9. During the past month, how much of a problem has it been for you to keep up enough 
enthusiasm to get things done? 
 
No problem at all _________ 
Only a very slight problem _________ 
Somewhat of a problem _________ 
A very big problem _________ 
 
10. Do you have a bed partner or share a room? 
 
No bed partner or do not share a room _________ 
Partner/ flatmate in other room _________ 
Partner in same room, but not same bed _________ 
Partner in same bed _________ 
 
11. If you have a bed partner or share a room, ask him/her how often in the past month you 
have had……… 
 
(a) Loud snoring. 
 
Not during the Less than Once or Three or more 
Past month________ once a week_______ twice a week_______ times a week______ 
 
(b) Long pauses between breaths while asleep. 
 
Not during the Less than Once or Three or more 
Past month________ once a week_______ twice a week_______ times a week______ 
 
(c) Legs twitching or jerking while you sleep. 
 
Not during the Less than Once or Three or more 
Past month________ once a week_______ twice a week_______ times a week______ 
 
(d) Episodes of disorientation or confusion during sleep. 
 
Not during the Less than Once or Three or more 
Past month________ once a week_______ twice a week_______ times a week______ 
 
(e) Other restlessness while you sleep: please describe_________________________ 
______________________________________________________________________________ 
 
Not during the Less than Once or Three or more 
Past month________ once a week_______ twice a week_______ times a week______ 
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 Posttraumatic stress disorder Check List – Civilian version (PCL-C) 
 
Sometimes things happen to people that are stressful or disturbing – events that involve 
experiencing or witnessing actual or threatened death or serious injury to oneself or 
others.  These events may cause the person to feel intense, fear, helplessness, or horror.  
These include earthquakes, very serious accidents or fires, physical assault or rape, being 
mugged or robbed, being physically or sexually abused, seeing other people killed or 
dead, being in a war or heavy combat, being diagnosed with a life-threatening illness or 
some other type of disaster. 
 
Have any of these or other kinds of things happened to you? 
 
Yes 
No 
 
Please check each relevant item on the list below.   
 
? Military combat 
? Violent attack (robbery, mugging, sexual/physical assault) 
? Being kidnapped 
? Taken hostage 
? Terrorist attack 
? Torture 
? Incarceration (POW, Concentration camp) 
? Natural or man-made disaster 
? Severe auto accident 
? Being diagnosed with a life-threatening illness 
? Sudden injury/serious accident 
? Observed someone hurt or killed 
? Learned about family member or close friend hurt or killed 
? Learned your child has a life-threatening illness 
? Other (Please describe) 
 
Please write the item from the above list that has been YOUR MOST SIGNIFICANT 
STRESSOR here:  
 
 
 
Please enter the month and year the stressor occurred: 
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 Please complete the following questions with reference to YOUR MOST SIGNIFICANT 
STRESSOR. 
   
Below is a list of problems and complaints that people sometimes have in response to 
stressful experiences. Please read each one carefully, then circle one of the numbers to 
indicate how much you have been bothered by that problem in the past month. 
 
1. Repeated, disturbing memories, thoughts or images of a stressful experience? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
2. Repeated, disturbing dreams of a stressful experience? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
3. Suddenly acting or feeling as if a stressful experience were happening again (as if you 
were reliving it)? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
4. Feeling very upset when something reminded you of a stressful experience?  
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
5. Having physical reactions (e.g., heart pounding, trouble breathing, sweating) when 
something reminded you of a stressful experience? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
6. Avoiding thinking about or talking about of a stressful experience or avoiding having 
feelings related to it? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
7. Avoiding activities or situations because they reminded you of a stressful experience? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
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 8. Trouble remembering important parts of a stressful experience?  
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
9. Loss of interest in activities you used to enjoy? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
10. Feeling distant or cut off from other people? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
11. Feeling emotionally numb or being unable to have loving feelings for those close to 
you? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
12. Feeling as if your future somehow will be cut short?  
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
13. Trouble falling or staying asleep? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
14. Feeling irritable or having angry outbursts? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
15. Having difficulty concentrating? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
16. Being “superalert” or watchful or on guard? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
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 17. Feeling jumpy or easily startled? 
 
1 2 3 4 5 
Not at all A little bit Moderately Quite a bit Extremely 
 
 
 
In response to the YOUR MOST SIGNIFICANT STRESSOR   have you… 
 
Reacted with feelings of intense fear, helplessness, or horror? YES  or  NO 
 
Felt that the event was a potential threat to your life and safety or the lives and safety of 
others?  YES  or  NO 
 
 
 
 44
 Multi-dimensional Fatigue Symptom Inventory (MFSI).   
 
Below is a list of statements that describe how people sometimes feel. Please read each 
item carefully, then circle the one number next to each item which best describes how 
true each statement has been for you in the past 7 days.  
 
 
 
 
Not at all A little Moderately Quite a bit Extremely 
1. I have trouble remembering things 0 1 2 3 4 
2. My muscles ache 0 1 2 3 4 
3. I feel upset 0 1 2 3 4 
4. My legs feel weak 0 1 2 3 4 
5. I feel cheerful 0 1 2 3 4 
6. My head feels heavy 0 1 2 3 4 
7. I feel lively 0 1 2 3 4 
8. I feel nervous 0 1 2 3 4 
9. I feel relaxed 0 1 2 3 4 
10. I feel pooped 0 1 2 3 4 
11. I am confused 0 1 2 3 4 
12. I am worn out 0 1 2 3 4 
13. I feel sad 0 1 2 3 4 
14. I feel fatigued 0 1 2 3 4 
15. I have trouble paying attention 0 1 2 3 4 
16. My arms feel weak 0 1 2 3 4 
17. I feel sluggish 0 1 2 3 4 
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 18. I feel run down 0 1 2 3 4 
19. I ache all over 0 1 2 3 4 
20. I am unable to concentrate 0 1 2 3 4 
21. I feel depressed 0 1 2 3 4 
22. I feel refreshed 0 1 2 3 4 
23. I feel tense 0 1 2 3 4 
24. I feel energetic 0 1 2 3 4 
25. I make more mistakes than usual 0 1 2 3 4 
26. My body feels heavy all over 0 1 2 3 4 
27. I am forgetful 0 1 2 3 4 
28. I feel tired 0 1 2 3 4 
29. I feel calm 0 1 2 3 4 
30. I am distressed 0 1 2 3 4 
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 Emotion Regulation Questionnaire (ERQ) 
 
We would like to ask you some questions about your emotional life, in particular, how 
you control (that is, regulate and manage) your emotions. We are interested in two 
aspects of your emotional life. One is your emotional experience, or what you feel like 
inside. The other is your emotional expression, or how you show your emotions in the 
way you talk, gesture, or behave. Although some of the following questions may seem 
similar to one another, they differ in important ways. For each item, please answer using 
the following scale: 
 
1-----------------2------------------3------------------4------------------5------------------6------------------7 
strongly           neutral                     strongly 
disagree              agree 
 
 
1. ____ When I want to feel more positive emotion (such as joy or amusement), I change 
what I’m thinking about. 
 
2. ____ I keep my emotions to myself. 
 
3. ____ When I want to feel less negative emotion (such as sadness or anger), I change 
what I’m thinking about. 
 
4. ____ When I am feeling positive emotions, I am careful not to express them. 
 
5. ____ When I’m faced with a stressful situation, I make myself think about it in a way 
that helps me stay calm. 
 
6. ____ I control my emotions by not expressing them. 
 
7. ____ When I want to feel more positive emotion, I change the way I’m thinking about 
the situation. 
 
8. ____ I control my emotions by changing the way I think about the situation I’m in. 
 
9. ____ When I am feeling negative emotions, I make sure not to express them. 
 
10. ____ When I want to feel less negative emotion, I change the way I’m thinking about 
the situation. 
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 Emotion Assessment Scale (EAS)   
 
For each word listed, place a slash (/) somewhere on the appropriate line to indicate how 
you are feeling at this moment. 
  
 
  Least Possible Most Possible
1. Surprised   
2. Afraid   
3. Disgusted   
4. Angry   
5. Guilty   
6. Anxious   
7. Sad   
8. Delighted   
9. Scared   
10. Astonished   
11. Repulsed   
12. Mad   
13. Ashamed   
14. Worried   
15. Disturbed   
16. Joyful   
17. Frightened   
18. Amazed   
19. Sickened   
20. Annoyed   
21. Humiliated   
22. Nervous   
23. Hopeless   
24. Happy   
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 Family of Origin Scale – short form (FOS) 
 
Instructions:   
Using the scale below as a guide, write a number besides each statement to indicate how 
much you agree with it. 
 
Strongly 
disagree Disagree Neutral Agree 
Strongly 
Agree 
1 2 3 4 5 
 
 
_________ In my family, we encouraged each other to develop new friendships. 
_________ 
 
Conflicts in my family never got resolved. 
_________ 
 
I found it difficult to understand what other family members said and how 
they felt. 
_________ 
 
In my family, I expressed just about any feeling I had. 
_________ 
 
My family was receptive to the different ways various family members 
viewed life. 
_________ 
 
I often had to guess at what other family members thought or how they 
felt. 
_________ 
 
My family members rarely expressed responsibility for their actions. 
_________ 
 
Sometimes in my family I did not have to say anything, but felt 
understood. 
_________ 
 
I found it easy to understand what other family members said and how 
they felt. 
_________ 
 
I found it difficult to express my own opinions in my family. 
_________ 
 
In my family, no one cared about the feelings of other family members. 
_________ 
 
In my family, certain feelings were not allowed to be expressed. 
_________ 
 
My family members usually were sensitive to one another’s feelings. 
_________ 
 
In my family, people took responsibility for what they did. 
_________ 
 
I remember my family as being warm and supportive. 
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 SCS 
Below is a list of social experiences.  For each question, please circle a number of how 
often you have had that experience in the past month. 
 
How often in the past month did your  
friends or family… Never Rarely 
Someti
mes Often 
1. change the subject when you tried to discuss your problems? 1 2 3 4 
2. not seem to understand your situation? 1 2 3 4 
3. avoid you? 1 2 3 4 
4. minimize your problems? 1 2 3 4 
5. seem to be hiding their feelings? 1 2 3 4 
6. 
act uncomfortable when you talked about your  
problems? 
1 2 3 4 
7. trivialize your problems? 1 2 3 4 
8. complain about their own problems when you wanted to share yours? 1 2 3 4 
9. act cheerful around you to hide their true feelings or concerns? 1 2 3 4 
10. tell you not to worry so much about your health? 1 2 3 4 
11. tell you to try not to think about your problems? 1 2 3 4 
12. give you the idea that they didn’t want to hear about your problems? 1 2 3 4 
13. 
make you feel as though you had to keep your 
feelings about your problems to yourself, 
because they made them feel uncomfortable? 
1 2 3 4 
14. 
make you feel as though you had to keep your 
feelings about your problems to yourself, 
because they made them feel upset? 
1 2 3 4 
15. let you down by not showing you as much love and concern as you would have liked? 1 2 3 4 
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 DUKE-SSQ 
 
Below is a list of things that other people do for us or give us that may be helpful or 
supportive.  Please read each statement carefully and indicate an answer that is closest to 
your situation.  Respond to each question by picking a number on the scale from “1” to 
“5” to tell me how you feel about the amount of support you receive.  Answering “1” 
would mean that you get that type of support “much less than you would like” and 
answering “5” would mean that you get that type of support “as much as you would like.”  
Answering with numbers 2, 3, and 4 would indicate that you feel somewhere in-between.  
For example, if asked if you get enough vacation time, answering “4” means that you get 
“almost” as much vacation time as you would like, but not quite as much as you would 
like.  Answer each item as best you can.  There are no right or wrong answers. 
   
 
 Much 
less 
than I 
would 
like 
   
As 
much 
as I 
would 
like 
1. I have people who care about what happens to me. 1 2 3 4 5 
2. I get love and affection. 1 2 3 4 5 
3. I get chances to talk to someone about problems at work or with my homework. 1 2 3 4 5 
4. I get chances to talk to someone I trust about my personal and family problems. 1 2 3 4 5 
5. I get chances to talk about money matters. 1 2 3 4 5 
6. I get invitations to go out and do things with other people. 1 2 3 4 5 
7. I get useful advice about important things in life. 1 2 3 4 5 
8. I get help when I’m sick in bed. 1 2 3 4 5 
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